Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2013 1
2014 1
2016 1
2018 1
2020 2
2021 3
2022 1
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

10 results

Results by year

Filters applied: . Clear all
Page 1
Showing results for schalk, dl[au]
Your search for Schalow DL[au] retrieved no results
Targeting GD2-positive Refractory/Resistant Neuroblastoma and Osteosarcoma with Anti- CD3 x Anti-GD2 Bispecific Antibody Armed T cells.
Yankelevich M, Thakur A, Modak S, Chu R, Taub J, Martin A, Schalk DL, Schienshang A, Whitaker S, Rea K, Lee DW, Liu Q, Shields A, Cheung NK, Lum LG. Yankelevich M, et al. Among authors: schalk dl. Res Sq [Preprint]. 2023 Nov 9:rs.3.rs-3570311. doi: 10.21203/rs.3.rs-3570311/v1. Res Sq. 2023. PMID: 37986911 Free PMC article. Preprint.
Bispecific Antibody Armed Metabolically Enhanced Headless CAR T Cells.
Thakur A, Scholler J, Kubicka E, Bliemeister ET, Schalk DL, June CH, Lum LG. Thakur A, et al. Among authors: schalk dl. Front Immunol. 2021 Jul 5;12:690437. doi: 10.3389/fimmu.2021.690437. eCollection 2021. Front Immunol. 2021. PMID: 34290709 Free PMC article.
Convalescent Plasma for Preventing Critical Illness in COVID-19: a Phase 2 Trial and Immune Profile.
Sturek JM, Thomas TA, Gorham JD, Sheppard CA, Raymond AH, Petros De Guex K, Harrington WB, Barros AJ, Madden GR, Alkabab YM, Lu DY, Liu Q, Poulter MD, Mathers AJ, Thakur A, Schalk DL, Kubicka EM, Lum LG, Heysell SK. Sturek JM, et al. Among authors: schalk dl. Microbiol Spectr. 2022 Feb 23;10(1):e0256021. doi: 10.1128/spectrum.02560-21. Epub 2022 Feb 23. Microbiol Spectr. 2022. PMID: 35196802 Free PMC article. Clinical Trial.
Maspin expression in prostate tumor elicits host anti-tumor immunity.
Dzinic SH, Chen K, Thakur A, Kaplun A, Bonfil RD, Li X, Liu J, Bernardo MM, Saliganan A, Back JB, Yano H, Schalk DL, Tomaszewski EN, Beydoun AS, Dyson G, Mujagic A, Krass D, Dean I, Mi QS, Heath E, Sakr W, Lum LG, Sheng S. Dzinic SH, et al. Among authors: schalk dl. Oncotarget. 2014 Nov 30;5(22):11225-36. doi: 10.18632/oncotarget.2615. Oncotarget. 2014. PMID: 25373490 Free PMC article.
Targeting CD138-/CD20+ Clonogenic Myeloma Precursor Cells Decreases These Cells and Induces Transferable Antimyeloma Immunity.
Lum LG, Thakur A, Kondadasula SV, Al-Kadhimi Z, Deol A, Tomaszewski EN, Yano H, Schalk DL, Ayash L, Zonder JA, Uberti JP, Abidi MH, Ratanatharathorn V. Lum LG, et al. Among authors: schalk dl. Biol Blood Marrow Transplant. 2016 May;22(5):869-78. doi: 10.1016/j.bbmt.2015.12.030. Epub 2016 Jan 28. Biol Blood Marrow Transplant. 2016. PMID: 26827660 Free PMC article. Clinical Trial.
CD20-targeted T cells after stem cell transplantation for high risk and refractory non-Hodgkin's lymphoma.
Lum LG, Thakur A, Liu Q, Deol A, Al-Kadhimi Z, Ayash L, Abidi MH, Pray C, Tomaszewski EN, Steele PA, Schalk DL, Yano H, Mitchell A, Dufresne M, Uberti JP, Ratanatharathorn V. Lum LG, et al. Among authors: schalk dl. Biol Blood Marrow Transplant. 2013 Jun;19(6):925-33. doi: 10.1016/j.bbmt.2013.03.010. Epub 2013 Mar 22. Biol Blood Marrow Transplant. 2013. PMID: 23529012 Free PMC article. Clinical Trial.